Jazz (JAZZ) (LNCR) (LTM) (MANH) (MDP) (NTRI) Ratings Reiterated

Jazz Pharmaceuticals, Inc. (NASDAQ: JAZZ), Lincare (NASDAQ: LNCR), Life Time Fitness (NYSE: LTM), Manhattan Associates, Inc. (NASDAQ: MANH), Meredith Corporation (NYSE: MDP) and NutriSystem Inc. (NASDAQ: NTRI) had ratings on them reiterated by analysts.

Piper Jaffray (NYSE:PJC) reiterated its “Overweight” rating on Jazz Pharmaceuticals, Inc. (JAZZ).

Citigroup (NYSE:C) reiterated its “Neutral” rating on Lincare (LNCR).

Piper Jaffray reiterated its “Overweight” rating on Life Time Fitness (LTM).

Benchmark Co. reiterated its “Buy” rating on Manhattan Associates, Inc. (MANH). They have a price target of $40.00 on the company.

Piper Jaffray reiterated its “Overweight” rating on Meredith Corporation (MDP).

Wedbush reiterated its “Outperform” rating on NutriSystem Inc. (NTRI).